☰

Brooke S. Barrett, Ph.D. - Publications

Affiliations: 
2009 Pharmaceutical Chemistry University of Kansas, Lawrence, KS, United States 
Area:
Pharmaceutical Chemistry, Physical Chemistry
Tree Info Similar researchers PubMed Report error

6/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Halemano K, Barrett BS, Heilman KJ, Morrison TE, Santiago ML. Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. Journal of Virology. 89: 4011-4. PMID 25589647 DOI: 10.1128/JVI.03399-14  0.386
2013 Halemano K, Barrett BS, Li SX, Harper MS, Smith DS, Heilman KJ, Santiago ML. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. Plos One. 8: e60500. PMID 23533681 DOI: 10.1371/journal.pone.0060500  0.321
2013 Halemano K, Harper MS, Guo K, Li SX, Heilman KJ, Barrett BS, Santiago ML. Humoral immunity in the Friend retrovirus infection model. Immunologic Research. 55: 249-60. PMID 22961660 DOI: 10.1007/S12026-012-8370-Y  0.398
2010 Markham AP, Barrett BS, Esfandiary R, Picking WL, Picking WD, Joshi SB, Middaugh CR. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine. Journal of Pharmaceutical Sciences. 99: 4497-509. PMID 20845449 DOI: 10.1002/Jps.22195  0.494
2010 Barrett BS, Markham AP, Esfandiary R, Picking WL, Picking WD, Joshi SB, Middaugh CR. Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates. Journal of Pharmaceutical Sciences. 99: 4488-96. PMID 20845448 DOI: 10.1002/Jps.22180  0.491
2008 Barrett BS, Picking WL, Picking WD, Middaugh CR. The response of type three secretion system needle proteins MxiH Δ5, BsaLΔ5, and PrgIΔ5 to temperature and pH Proteins: Structure, Function and Genetics. 73: 632-643. PMID 18491382 DOI: 10.1002/Prot.22085  0.631
Low-probability matches (unlikely to be authored by this person)
2014 Halemano K, Guo K, Heilman KJ, Barrett BS, Smith DS, Hasenkrug KJ, Santiago ML. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. Proceedings of the National Academy of Sciences of the United States of America. 111: 7759-64. PMID 24821801 DOI: 10.1073/Pnas.1403361111  0.269
2011 Smith DS, Guo K, Barrett BS, Heilman KJ, Evans LH, Hasenkrug KJ, Greene WC, Santiago ML. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. Plos Pathogens. 7: e1002284. PMID 21998583 DOI: 10.1371/Journal.Ppat.1002284  0.236
2016 Li SX, Barrett BS, Guo K, Santiago ML. Tetherin/BST-2: Restriction Factor or Immunomodulator? Current Hiv Research. 14: 235-46. PMID 26957198 DOI: 10.2174/1570162X14999160224102752  0.23
2014 Li SX, Barrett BS, Heilman KJ, Messer RJ, Liberatore RA, Bieniasz PD, Kassiotis G, Hasenkrug KJ, Santiago ML. Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. Journal of Immunology (Baltimore, Md. : 1950). 193: 306-16. PMID 24872193 DOI: 10.4049/Jimmunol.1400490  0.228
2014 Gibbert K, Francois S, Sigmund AM, Harper MS, Barrett BS, Kirchning CJ, Lu M, Santiago ML, Dittmer U. Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3. Retrovirology. 11: 126. PMID 25539593 DOI: 10.1186/s12977-014-0126-4  0.222
2013 Li SX, Barrett BS, Harper MS, Heilman KJ, Halemano K, Steele AK, Guo K, Silverman RH, Santiago ML. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection. Virology. 443: 134-42. PMID 23725696 DOI: 10.1016/J.Virol.2013.05.009  0.152
2014 Barrett BS, Guo K, Harper MS, Li SX, Heilman KJ, Davidson NO, Santiago ML. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. Virology. 468: 601-8. PMID 25303118 DOI: 10.1016/J.Virol.2014.09.006  0.147
2012 Barrett BS, Smith DS, Li SX, Guo K, Hasenkrug KJ, Santiago ML. A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. Plos Pathogens. 8: e1002596. PMID 22457621 DOI: 10.1371/Journal.Ppat.1002596  0.146
2016 Li SX, Barrett BS, Guo K, Kassiotis G, Hasenkrug KJ, Dittmer U, Gibbert K, Santiago ML. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Scientific Reports. 6: 20425. PMID 26846717 DOI: 10.1038/Srep20425  0.138
2013 Harper MS, Barrett BS, Smith DS, Li SX, Gibbert K, Dittmer U, Hasenkrug KJ, Santiago ML. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3. Journal of Immunology (Baltimore, Md. : 1950). 190: 1583-90. PMID 23315078 DOI: 10.4049/Jimmunol.1202920  0.125
2015 Harper MS, Guo K, Gibbert K, Lee EJ, Dillon SM, Barrett BS, McCarter MD, Hasenkrug KJ, Dittmer U, Wilson CC, Santiago ML. Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms. Plos Pathogens. 11: e1005254. PMID 26529416 DOI: 10.1371/Journal.Ppat.1005254  0.091
2011 Santiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. Journal of Virology. 85: 189-99. PMID 20980520 DOI: 10.1128/Jvi.01838-10  0.085
2009 Redente EF, Dwyer-Nield LD, Barrett BS, Riches DW, Malkinson AM. Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice. Anticancer Research. 29: 5095-101. PMID 20044622  0.081
2010 Rice PL, Barrett BS, Fritz JM, Srebernak MC, Kisley LR, Malkinson AM, Dwyer-Nield LD. Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells. Experimental Lung Research. 36: 558-71. PMID 20815659 DOI: 10.3109/01902148.2010.491891  0.066
2002 Kisley LR, Barrett BS, Bauer AK, Dwyer-Nield LD, Barthel B, Meyer AM, Thompson DC, Malkinson AM. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Research. 62: 6850-6. PMID 12460898  0.06
2002 Kisley LR, Barrett BS, Dwyer-Nield LD, Bauer AK, Thompson DC, Malkinson AM. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis. 23: 1653-60. PMID 12376474 DOI: 10.1093/Carcin/23.10.1653  0.058
2005 Dwyer-Nield LD, Srebernak MC, Barrett BS, Ahn J, Cosper P, Meyer AM, Kisley LR, Bauer AK, Thompson DC, Malkinson AM. Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines. Carcinogenesis. 26: 1196-206. PMID 15746162 DOI: 10.1093/Carcin/Bgi061  0.055
2012 Naylor E, Aillon DV, Barrett BS, Wilson GS, Johnson DA, Johnson DA, Harmon HP, Gabbert S, Petillo PA. Lactate as a biomarker for sleep. Sleep. 35: 1209-22. PMID 22942499 DOI: 10.5665/Sleep.2072  0.012
Hide low-probability matches.